Characteristics of the study group
. | AML . | ALL . |
|---|---|---|
| No. patients | 8 | 17 |
| Age, y, median (range) | 8.5 (1-18) | 12 (4-19) |
| Sex, M/F | 5/3 | 10/7 |
| CRD1, wk, median (range) | 33 (9-89) | 51 (0-256) |
| Salvage status, median (range) | 2 (1-6) | 3 (1-5) |
| Prior transplantations | 5 | 4 |
. | AML . | ALL . |
|---|---|---|
| No. patients | 8 | 17 |
| Age, y, median (range) | 8.5 (1-18) | 12 (4-19) |
| Sex, M/F | 5/3 | 10/7 |
| CRD1, wk, median (range) | 33 (9-89) | 51 (0-256) |
| Salvage status, median (range) | 2 (1-6) | 3 (1-5) |
| Prior transplantations | 5 | 4 |
AML refers to acute myeloid leukemia; ALL, acute lymphoblastic leukemia; and CDR1, the duration of the first complete remission.